General Overview

In the developing world, the subject of personal and public health is of the utmost importance, and new medical products, services, and solutions are currently in high demand. The medical sector is broad, and includes numerous and disparate fields. One can make a broad generalization and divide the medical field into two categories: disposable products and capitalized equipment.
 

The global medical industry has attracted considerable attention, and is the beneficiary of support and incentives from governments and countries interested in promoting innovation, as well as from the financial markets.

 

The medical sector is heavily regulated, although the degree of regulation varies from country to country. In order to receive authorization to market a new product, a company must meet numerous regulatory provisions as determined by bodies such as the American Food and Drug Administration (FDA), and the Commissioner of the European Union (CE mark).

 

For the most part, the process of receiving authorization from the FDA is more complicated and takes longer than to receive authorization from the CE. Receiving FDA authorization is also usually dependent upon the results of clinical trials conducted by the companies, which serve to prove that their product in fact serves its purpose.

 

There are wide differences between the companies that operate in the medical equipment field regarding the duration, complexity, and cost of clinical trials, as well as the probability of receiving regulatory approval. The process for receiving authorization for companies developing medical equipment is shorter and less expensive than the process for companies that develop pharmaceuticals, and their chances of success in the medical field are therefore higher.

 

The medical equipment field is characterized by a lower technological risk level relative to the other branches of the health, pharmaceutical, and biotechnology sectors, and has a success rate of 50-60%.

 

The costs of clinical trials and the expense of bringing products to market in the medical equipment field are much lower than in the pharmaceutical field, and in most cases companies are able to fund the experiments from money that is raised from investors. It is usually only in the relatively late stages of development that these companies join with strategic partners in order to market and distribute their product (a distributor with global deployment or a number of distributors in different geographical areas.)

 

E&O works to identify companies that possess new, proven technologies in the medical field, with the goal of leading businesses to a joint success in the global market. 

 


 

In order to view this page you need Flash Player 9+ support.

Get Adobe Flash player